Literature DB >> 12424179

Risk factor thresholds. Threshold is 37 000 pounds sterling per QALY.

Michael A Soljak.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12424179      PMCID: PMC1124591     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  11 in total

1.  Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment.

Authors:  D M Pickin; C J McCabe; L E Ramsay; N Payne; I U Haq; W W Yeo; P R Jackson
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 3.  Risk factor thresholds: their existence under scrutiny.

Authors:  M R Law; N J Wald
Journal:  BMJ       Date:  2002-06-29

4.  Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.

Authors:  I J Schatz; K Masaki; K Yano; R Chen; B L Rodriguez; J D Curb
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

5.  Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance.

Authors:  S Malhotra; R S Karan; P Pandhi; S Jain
Journal:  Postgrad Med J       Date:  2001-11       Impact factor: 2.401

6.  Cholesterol and mortality. 30 years of follow-up from the Framingham study.

Authors:  K M Anderson; W P Castelli; D Levy
Journal:  JAMA       Date:  1987-04-24       Impact factor: 56.272

7.  Assessing possible hazards of reducing serum cholesterol.

Authors:  M R Law; S G Thompson; N J Wald
Journal:  BMJ       Date:  1994-02-05

Review 8.  Epidemiology of adverse drug reactions in the elderly by drug class.

Authors:  R J Beyth; R I Shorr
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 4.271

9.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

10.  Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989.

Authors:  A Okayama; H Ueshima; M G Marmot; M Nakamura; Y Kita; M Yamakawa
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.